Want to see APLM full AI Analyst Report?
Uproleselan
Relapsed/Refractory Aml
Phase III
Terminated
Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML
Sep 14, 2021
―
Apl-102 Capsules
Advanced Solid Tumor
Phase I
Suspended
APL-102 Capsule in Patients With Advanced Solid Tumors
Aug 22, 2021
―
Uproleselan
Relapsed/Refractory Aml
Phase I
Completed
Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients
Mar 22, 2021
―
Apl-101 Oral Capsules
Solid Tumors, Pancreatic Cancer, Renal Cancer, Lung Cancer, Gastric Cancer, Nsclc, Advanced Cancer, Glioblastoma Multiforme, Brain Tumor, Gastroesophageal Junction Adenocarcinoma, Colon Cancer, Thyroid Cancer, Egfr Gene Mutation, Met Amplification, Hgf, Met Alteration, Met Fusion, Exon 14 Skipping
Phase II
Recruiting
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Jun 01, 2017
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Apollomics (APLM) have in its pipeline
APLM is currently developing the following drugs: Uproleselan, Apl-102 Capsules, Uproleselan. These drug candidates are in various stages of clinical development as the company works toward FDA approval.